Gary Clark Biddle - 18 Mar 2026 Form 3 Insider Report for BELITE BIO, INC (BLTE)

Role
Director
Signature
/s/ Gary Clark Biddle
Issuer symbol
BLTE
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 14:28:13 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Biddle Gary Clark Director UNIT 602, 296 FLINDERS STREET, MELBOURNE, AUSTRALIA /s/ Gary Clark Biddle 18 Mar 2026 0002107993

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BLTE Stock Option (right to buy) 18 Mar 2026 Ordinary Shares 50,000 $6.00 Direct F1
holding BLTE Stock Option (right to buy) 18 Mar 2026 Ordinary Shares 60,000 $58.88 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest (i) as to 20,000 ordinary shares subject to the option in 12 equal and continuous monthly installments for each full month of services completed following April 28, 2022, and (ii) as to the remaining 30,000 ordinary shares subject to the option in 24 equal and continuous monthly installments for each full month of services completed following the first anniversary of April 28, 2022, subject to continued service to the Issuer on each such date.
F2 The option shall vest as to 60,000 ordinary shares subject to the option in 36 equal and continue monthly installments for each full month of services completed following April 15, 2025, subject to continued service to the Issuer on such date.

Remarks:

Exhibit 24 - Power of Attorney